SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is trending as investors react to a significant sell-off following disappointing revenue guidance and projections of a steep decline in the Chinese market. Community sentiment is deeply divided, with some investors viewing the price drop as a rare entry point for a long-term 'dividend aristocrat' play, while others warn of a 'value trap' due to stalled growth and ongoing concerns regarding management's turnaround strategy.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense market speculation driven by recurring buyout rumors involving major technology and aerospace players like SpaceX and Amazon. Investors are actively debating the potential valuation of the company's critical spectrum assets and satellite infrastructure, fueled by anticipation of upcoming earnings and recent industry partnerships.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

Restoration Hardware is experiencing high volatility as investors react to mixed quarterly earnings and the companys ongoing struggles with trade tariffs and a challenging housing market. While the community remains deeply divided, with many debating whether the stock is a long-term value opportunity or a failing luxury retailer, the stock continues to see significant short interest and intense speculation regarding future legal developments surrounding trade policy.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors react to the company moving its earnings release date to April Fools' Day and recent partnership announcements, fueling intense debate between bulls expecting a turnaround and bears citing management concerns. The community is actively discussing the potential impact of pending federal cannabis rescheduling and the broader influence of upcoming White House policy meetings on the sector's performance.

Mega Fortune Co., Ltd. operates as a holding company which provides information technology services. It specializes in delivering comprehensive IoT solutions and services across various industries. The firm offers low carbon property management, energy, stock and GreenTech management services. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

Mega Fortune is trending as investors debate its potential for volatile, high-percentage swings characteristic of low-float Chinese IPOs, drawing comparisons to previous market runners. While some traders are aggressively positioning for a rapid squeeze fueled by lock-up dynamics, many participants are cautioning others about the significant risks associated with its history of extreme volatility and pump-and-dump patterns.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing heightened retail interest as traders monitor its history of volatile, low-float runs and speculate on the potential for a short squeeze. Community discussion is heavily focused on the stock's lack of available shares to borrow, extreme cost-to-borrow fees, and comparisons to previous multi-bagger rallies, with many debating whether this represents a genuine reversal or a potential liquidity trap.

SharonAI Holdings, Inc. engages in providing high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure technologies. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is trending due to the announcement of a massive multi-year AI infrastructure contract, which has sparked intense community debate regarding its low-float potential for a significant squeeze. Investors are actively discussing the stock's future, weighing the deal's long-term value against frustrations over current volume, price action, and perceived manipulation.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is seeing heightened community discussion and bullish sentiment following a significant stake acquisition by Bill Ackman, driving speculation about a potential turnaround and a massive short squeeze. Investors are closely monitoring key technical resistance levels while debating the impact of upcoming debt obligations and the company's long-term strategy.

Tema ETF Trust - Tema Space Innovators ETF

The Tema Space Innovators ETF is trending as investors seek exposure to the anticipated SpaceX IPO and broader space sector growth. While some community members are optimistic about its focus on space technology and satellite infrastructure, others are actively debating its low assets under management and comparing its potential performance and strategy to other existing space-linked investment vehicles.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending due to a 14.2 billion dollar deal to repurchase a significant stake in its Ireland Fab 34 joint venture, signaling an aggressive move to regain strategic manufacturing control amid an AI-focused operational pivot. The community remains deeply divided, with some investors viewing the stock as a prime turnaround opportunity while others express significant concern over broader geopolitical instability and the company's long-term competitive position against sector peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AbCellera Biologics Eyes Integrated Biotech Shift; ABCL635 Phase II Data Due in Q3 at Forum

AbCellera Biologics (NASDAQ:ABCL) is working to evolve from a technology-enabled drug discovery partner into what the company described as an integrated biotech with internal programs advancing through mid- to late-stage development, according to comments from Senior Director of Strategic Finance an...

AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says

AbCellera Biologics (NASDAQ:ABCL) is positioning itself as a more pipeline-driven biotechnology company after more than a decade of platform investment, according to comments from Senior Director of...

DNB Asset Management AS Buys Shares of 656,208 AbCellera Biologics Inc. $ABCL

DNB Asset Management AS purchased a new position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL - Free Report) in the third quarter, according to the company in its most recent disclosure with...

What Sparked AbCellera Biologics To Soar Over 9% After Hours

AbCellera Biologics shares jumped 9.3% after hours to $3.52 following an 83% earnings beat in Q4 2025.read more...

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates

ABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of +83.56% and +565.48%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

AbCellera Biologics Q4 Earnings Call Highlights

AbCellera Biologics (NASDAQ:ABCL) used its full-year 2025 business update call to emphasize that it has completed its transition toward becoming a vertically integrated, clinical-stage biotech and is...

AbCellera Biologics (NASDAQ:ABCL) Announces Quarterly Earnings Results

AbCellera Biologics (NASDAQ:ABCL - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.03) earnings per share for the quarter, beating analysts' consensus...

AbCellera Reports Full Year 2025 Business Results

AbCellera (Nasdaq: ABCL) today announced financial results for the full year 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. In 2025...

AbCellera Biologics Inc. (NASDAQ:ABCL) Given Average Recommendation of "Hold" by Brokerages

AbCellera Biologics Inc. (NASDAQ:ABCL - Get Free Report) has received a consensus recommendation of "Hold" from the six ratings firms that are presently covering the stock, Marketbeat reports. One...

AbCellera Biologics (ABCL) Projected to Post Earnings on Tuesday

AbCellera Biologics (NASDAQ:ABCL) will be releasing its Q4 2025 earnings after the market closes on Tuesday, February 24. (View Earnings Report at...

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

Current Price	$3.53
Prev Close	$3.49
Open	$3.53
Dividend Yield	0.00%
50-Day Moving Average	$3.49
Beta	1.49
Avg. Volume	4.56M
PE Ratio	-7.12

52-Week High	$6.52
52-Week Low	$1.89
Market Capitalization	$1.06B
EPS (Annual)	-$0.4901
Price to Book	1.08
Revenue Per Employee	$133,679.71

ABCL
AbCellera Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABCL News

ABCLAbCellera Biologics Inc